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ABSTRACT
Cholinergic urticaria (CU) has clinically characteristic features, and has been frequently described in the litera-
ture. However, despite its comparatively old history, the pathogenesis and classification remains to be clarified.
CU patients are occasionally complicated by anhidrosis andor hypohidrosis. This reduced-sweat type should
be included in the classification because the therapeutic approaches are different from the ordinary CU. It is
also well-known that autologous sweat is involved in the occurrence of CU. More than half of CU patients may
have sweat hypersensitivity. We attempt to classify CU and address the underlying mechanisms of CU based
on the published data and our findings. The first step for classification of CU seems to discriminate the pres-
ence or absence of hypersensitivity to autologous sweat. The second step is proposed to determine whether
the patients can sweat normally or not. With these data, the patients could be categorized into three subtypes:
(1) CU with sweat hypersensitivity; (2) CU with acquired anhidrosis andor hypohidrosis; (3) idiopathic CU. The
pathogenesis of each subtype is also discussed in this review.
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INTRODUCTION
Cholinergic urticaria (CU) is a rare condition, but its
incidence might be higher than that expected by gen-
eral physicians. CU is clinically characterized by
pinpoint-sized, highly pruritic wheals. Although the
symptoms subside rapidly, commonly within one
hour, CU may significantly impair the quality of life,
especially sporting and sexual activities.1 This unique
disease was described by Duke in 1924,2 however,
despite its comparatively old history, the pathogene-
sis and classification remains to be clarified. CU is
typically provoked by stimulation such as exercise,
warmth, and emotional distress, which increases the
body core temperature and promotes sweating.3,4
Since acetylcholine is known to induce both sweat-
ing and wheals when injected intradermally,4 it has
been considered that this sweating-associated, syr-
ingeal orifice-coincident wheal is mediated by acetyl-
choline. In fact, acetylcholine stimulation can elicit
hives as seen in CU, suggesting that the etiology of
CU includes certain events that are triggered by a
cholinergic stimulus. A well-known hypothesis has
been put forward to explain the pathogenesis of CU.
The patients are hypersensitive to unknown sub-
stances in their sweats and develop wheals in re-
sponse to sweat substance leaking from the syringeal
ducts to the dermis possibly by obstruction of the
ducts.5,6 This “sweat hypersensitivity” hypothesis has
been supported by the fact that not all but some pa-
tients with CU exhibit a positive reaction to intrade-
mal injection of the patients’ own diluted sweat as
well as acetylcholine.7 Based on the distinct re-
sponses to the autologous factors and clinical charac-
teristics, Fukunaga et al. proposed two subtypes in
the entity of CU, sweat hypersensitivity (non-
follicular) type and follicular type.7
However, sweat hypersensitivity theory lacks suffi-
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cient evidence and can not encompass the whole eti-
ology of CU. CU is occasionally associated with de-
pressed sweating, as reported under the name of an-
hidrosis (complete lack of sweating) or hypohidrosis
(incomplete lack of sweating).8 There have been re-
ported 29 patients with CU with anhidrosis andor
hypohidrosis in the literature,8-32 and notably, 26 pa-
tients are Japanese. This type of CU may be caused
by reduced expression of acetylcholine receptor but
not by sweat hypersensitivity, as described below. In
addition, two Japanese patients with CU had episodes
of seizures upon occurrence of urticaria.33,34 Given
that acetylcholine mediates epileptic seizures,35,36 sei-
zures possibly occur when steroid therapy induces
the re-expression of acetylcholine receptors in the
brain.
By exploring the enigmatic relationship between
wheal formation and sweating, we have addressed
the general mechanism underlying CU.37 In this re-
view, we show the relationship between sweating and
the pathogenesis of CU according to the published
findings and propose the classification of CU based
on the mechanisms.
CLINICAL SUBTYPES OF CU ACCORDING
TO RESPONSES TO SWEAT
Since CU is not a homogeneous disease, its classifica-
tion is necessary for the clinical use. However, few at-
tempts have been performed to classify CU in the lit-
erature, and there is no solid consensus on the cate-
gorization. Horikawa et al. observed that a strong hy-
persensitivity to sweat was not observed in all CU pa-
tients and assumed other factors than sweat hyper-
sensitivity are also involved in the pathogenesis of
CU.38 Some patients with chronic urticaria have
autoantibodies to FcεRI or IgE, and the autologous
serum skin test (ASST) has been used to detect the
autoantibodies.39,40 Horikawa et al. also found that 8
of 15 patients with CU showed responsiveness to
ASST. While the follicular manifestation of wheal was
mainly associated with positive ASST, the non-
follicular hives tended to show strong hypersensitiv-
ity to sweat and were probably associated with sweat
ducts. Based on this observation, they proposed to
classify CU into two subtypes: (1) the sweat hyper-
sensitivity type (non-follicular type) showing non-
follicular hives, strong hypersensitivity to autologous
sweat, development of satellite wheals following ace-
tylcholine injection, and negative ASST; and (2) the
follicular type showing follicular hives and positive
ASST without hypersensitivity to autologous sweat or
satellite wheals.38 It remains unclear how ASST in-
duces the follicular eruption. It is notable that some
CU patients have hypersensitivity to both autologous
sweat and serum.
In the above simple classification, it should be clari-
fied whether the sweat and serum hypersensitivities
can encompass the whole spectrum of CU. In addi-
tion, there are some important issues to be dissolved.
CU patients are occasionally complicated by anhidro-
sis andor hypohidrosis. This reduced-sweat type
should be included in the classification because the
therapeutic approaches are different from the ordi-
nary CU. It has been thought that the anhidrosis
andor hypohidrosis are caused by obstruction of
sweat orifice. However, the sweat reduction is not
necessarily associated with poral obstruction.
Nakamizo et al. proposed four subtypes of CU: (1)
CU with poral occlusion; (2) CU with acquired gener-
alized hypohidrosis; (3) CU with sweat allergy; and
(4) idiopathic CU.41 The incidence of overlapping of
(1)-(3) is an important issue to elucidate their inde-
pendence and concurrence.
One of the interesting observations in CU is that
the sweat ducts are obstructed by lymphocytic in-
flammation around the ducts, and resultant retention
and subsequent leakage of sweat from the damaged
ducts induce wheals because of sweat hypersensitiv-
ity.5,6 Given this mechanism, CU with anhidrosis
andor hypohidrosis might belong to all of “CU with
poral occlusion”, “CU with acquired generalized hy-
pohidrosis”, and “CU with sweat allergy”. However,
several observations concerning CU with anhidrosis
andor hypohidrosis are not in accordance with the
conventional poral occlusionsweat leakage theory.
First, the symptoms are usually exacerbated in winter
and resolved in summer, although it can be explained
with the hypothesis that daily sweating in summer in-
hibits the formation of keratotic plugs to prevent the
occurrence of CU.6 However, the vast majority of this
type of CU have been reported from Asia, whose cli-
mate is hot and humid, and the disease is rare in
Europe, where it is cool and dry. This regional diver-
gence in the occurrence of the disease is not consis-
tent with the poral occlusionsweat leakage theory.
Second, in the literature, few of the patients with CU
with anhidrosis or hypohidrosis showed positive re-
sults of the intradermally injected autologous sweat,
suggesting that sweat hypersensitivity is not respon-
sible for this form of CU. In addition, if sweat hyper-
sensitivity is the mechanism, the anhidrotic area
should be the predilection site for wheals, but wheals
cannot occur on the anhidrotic area.37 We found mo-
saic distribution of hypohidrotic or anhidrotic areas
on the body surface, and the patients develop wheals
on the hypohidrotic area. Therefore, we suggest that
“CU with acquired generalized hypohidrosis” and
“CU with poral occlusion” are mostly independent.
Considering all these findings, the first step for
classification of CU seems to discriminate the pres-
ence or absence of hypersensitivity to autologous
sweat. The second step is proposed to determine
whether the patients can sweat normally or not. With
these data, the patients could be categorized into
three subtypes: (1) CU with sweat hypersensitivity;
(2) CU with acquired anhidrosis andor hypohidro-
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Table　1　Clinical subtypes of CU according to responses to sweat
Subtype Sweat allergy Anhidrosis/hypohidrosis
Intradermal test 
for acetylcholine Pathology Treatment
Sweat hypersensitivity Positive None Positive Infi ltrate of lymphocytes 
around sweat glands
Desensitization
Anhidrosis or hypohidrosis Mostly negative Necessary, 
mosaic
Partial positive Normal Systemic steroid
Idiopathic Negative None Negative Normal Antihistamines
sis; (3) idiopathic CU (Table 1). It is suggested that
only a small percentage of the patients belong to the
combination of (1) and (2).
ASSESSMENTS OF SWEAT HYPERSENSI-
TIVITY
Several studies have suggested the involvement of
autologous sweat in the occurrence of CU, as repre-
sented by the well-known finding that a considerable
percentage of the patients show positive reactions to
diluted own sweat by intradermal tests.5,7,8,42 In this
procedure, sweat is collected after exercise from the
forearm of each patient, sterilized by using a 0.45-mm
polyethersulfone membrane, and preserved at -80℃
until use. Sweat samples are diluted at 1 : 100 with
physiological saline before the skin test. Serum is si-
multaneously obtained by centrifugation of venous
blood. Samples of autologous diluted sweat (0.02
mL), autologous serum (0.05 mL), and 0.9% sterile sa-
line as control (0.02 or 0.05 mL) are separately in-
jected intradermally into the forearm of each patient
at the time when they have no wheal. The diameters
of wheals and erythema are measured 15 min after in-
jection. Reactions are assessed as positive when the
diameter of wheal induced by sweat and serum is 6
mm or more. The sterile saline, 0.05 and 0.02 mL,
usually induces mild edema less than 4 mm and less
than 2 mm, respectively. In our study, 11 (64.7%) of
16 patients with CU showed positive reactions to
their own 1100 diluted sweat by skin test.7 Hide et
al. have developed histamine release test (HRT) us-
ing leukocytes of patients,42 which is more reliable
than skin test. Results of skin test may be affected by
both sweat constituents and skin conditions such as
hypersensitivity, whereas HRT with standardized
semi-purified sweat represents basophile conditions
regardless of the constituent of sweat of individual
subjects. This assay has been already commercial-
ized. The collection of sweat is not an easy manipula-
tion. HRT could be a potent practically beneficial tool
to screen sweat hypersensitivity. Recently, they de-
veloped also histamine release-neutralization (HRN)
assay by using the semi-purified and standardized
sweat antigen, and showed high sensitivity (0.87) and
specificity (0.522) to type I hypersensitivity against
sweat in patients with AD andor CU.43
ASSESSMENTS OF SWEATING CONDITION
CU is occasionally accompanied by anhidrosis or hy-
pohidrosis. The sweating condition can be evaluated
by exercise-induced sweating, which is assessed by
iodine-starch test. Provocation is performed by exer-
cise using an ergometer. The areas of hypohidrosis
and anhidrosis are identified with iodine-starch stain-
ing.6 In this assessment, normal hidrotic areas are
changed from white to dark blue, whereas the an-
hidrotic skin remains white. To clarify the area of an-
hidrosis, photographs of both areas are taken, and
skin biopsy specimens can be taken from both an-
hidrotic and hypohidrotic areas for further histologi-
cal examination. In CU patients with anhidrosis or hy-
pohidrosis, we have clearly demonstrated that the
depressed-sweat areas are divided into the two areas,
anhidrotic and hypohidrotic ones, and there is no nor-
mal sweating area in the patients.37 Although sweat-
ing is reduced in the hypohidrotic area, a substantial
degree of sweating is still observed, as compared to
the anhidrotic area, where complete lack of sweating
is seen. As judged from the four patients, anhidrotic
areas are seen in a large mosaic pattern, and the four
limbs and face may be the predilection sites.37
ROLE OF ACETYLCHOLINE IN CU
Acetylcholine is known to induce degranulation in rat
mast cells.44,45 Subcutaneous injection of a choliner-
gic agent, carbaminoylcholine, induced sweating and
numerous pin-point hives that are similar to CU.42
Thus, it is believed that acetylcholine plays an essen-
tial role in the development of CU. On the other
hand, there is a skeptical opinion for acetylcholine, as
it remains unclear whether acetylcholine stimulates
degranulation from human mast cells. To address the
issue, we used LAD2 cells, a human mast cell line, for
in vitro assay, and found that acetylcholine dose-
dependently induced the degranulation of the mast
cells,37 suggesting an essential role of acetylcholine
in the development of CU.
PATHOGENESIS OF CU WITH SWEAT HY-
PERSENSITIVITY
Tanaka et al. found that the sweat-induced release of
histamine from basophils is mediated by specific IgE
for the partially purified antigen present in the sweat
of patients with atopic dermatitis.46 The sweat hyper-
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Fig.　1　A schematic model of the induction of wheals and pain in CU with hypohidrosis. In the normal hidrotic area, ace-
tylcholine released from nerves upon exercise is completely trapped by acetylcholine receptor of eccrine glands and nor-
mally induces sweating. In the hypohidrotic area, acetylcholine released from nerves upon exercise cannot be complete-
ly trapped by acetylcholine receptor of eccrine glands and overfl ows to the adjacent mast cells. Subsequently, 
degranulation of the mast cells induces wheals and pain.
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sensitivities of CU and atopic dermatitis seem to be
virtually the same, and therefore, the sweat-induced
histamine release from basophils may also be medi-
ated by a specific IgE for sweat in atopic dermatitis as
well as CU. The response depends on the concentra-
tion of sweat to some extent, which is compatible
with the clinical observation that few patients with
CU develop urticaria with small amount of sweating.
Takahagi et al. recently reported that 23 (65.7%) of 35
CU patients associated with atopic diathesis showed
basophil histamine release with semi-purified sweat
antigen.47 More than half of CU patients may have
sweat hypersensitivity. Based on the observation that
wheals are coincident with perspiration points of
sweating, it is assumed that sweating causes pin-point
wheals at sweat ducts that might allow sweat to
leak.38 However, there has been no strong evidence
for the sweat leak to the dermis.
PATHOGENESIS OF CU WITH ANHIDROSIS
ANDOR HYPOHIDROSIS
Various causes of anhidrosis or hypohidrosis have
been reported, including absence of sweat glands, im-
paired function of sweat glands, poral occlusion,6 or
dysfunction of sympathetic nerves in neuropathies.48
The causes are a matter of controversies. We address
the mechanism based on our recent study.37 As de-
scribed in the clinical subtypes chapter, the sweat-
depressed areas can be divided into two distinct ar-
eas; the hypohidrotic area, where a substantial de-
gree of sweating is still observed, and the anhidrotic
area, where the skin completely lacks sweating. By
examining the sweating condition on the whole body
surface, it was revealed that anhidrosis and hypo-
hidrosis comorbid in the patients with CU.37 Of note
is the observation that the patients develop wheals in
the hypohidrotic but not anhidrotic area, demonstrat-
ing that the occurrence of wheals is associated with
sweating. In consistent with the result of the exercise
induction test, wheals are provoked by the intrader-
mal acetylcholine injection in the hypohidrotic but
not anhidrotic area.
We performed the morphological and functional
analyses of sweat glands in CU patients and found the
involvement of acetylcholine receptor for sweating. In
the anhidrotic and hypohidrotic areas, there is the
gradient disturbance of the expression of cholinergic
receptor muscarin 3 (CHRM3). CHRM3 is not ex-
pressed in the anhidrosis area, but its expression is
retained to some extent in the hypohidrotic area. His-
Pathogenesis of Cholinergic Urticaria
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tologically, there is an infiltrate of CD4+ and CD8+ T
cells around the eccrine glands in the anhidrotic area,
suggesting the inflammation-attenuated expression of
the acetylcholine receptor. The expression pattern of
CHRM3 on mast cells is similar to the eccrine gland
epithelial cells in the anhidrotic and hypohidrotic ar-
eas. Acetylcholine receptor mediates wheal develop-
ment,48-50 and acetylcholine can induce degranulation
of mast cells, as shown in our study,37 and the past
studies.44,45 The data lead to the theory that CHRM3
expression is responsible for both sweating and
wheal development. In the hypohidrotic area, we are
tempting to speculate that acetylcholine released
from nerves upon exercise cannot be completely
trapped by acetylcholine receptor of eccrine glands
and overflows to the adjacent mast cells (Fig. 1). In
this scenario, it is assumed that mast cells can pro-
duce histamine in response to acetylcholine, because
mast cells in the hypohidrotic area express some de-
gree of CHRM3.37
IDIOPATHIC CU
CU is generally categorized into two major subtypes,
CU associated with or without sweat hypersensitivity.
We propose that the majority of CU patients with an-
hidrosis andor hypohidrosis belong to CU associ-
ated without sweat hypersensitivity. However, there
still exist unclassified patients with CU despite full ex-
aminations. Such patients without any clue to diagno-
sis are categorized into idiopathic CU. We need to
further clarify the causative agents and underlying
mechanism in this type of CU.
TREATMENT OF CU
Desensitization with autologous sweat has recently
been attempted in CU with sweat hypersensitivity.
Tanaka et al. demonstrated that desensitization using
partially purified sweat antigen was effective in a pa-
tient with CU.51 Kozaru et al. performed rapid desen-
sitization with autologous sweat in 6 CU patients with
sweat hypersensitivity, and succeeded in 5 of the 6
patients.52 Desensitization therapy may become a fa-
miliar choice of treatment for CU patients with sweat
hypersensitivity. A severe CU patient with sweat al-
lergy has been successfully treated with an anti-IgE
antibody, omalizumab,53 suggesting that an IgE-
mediated response is involved in the pathogenesis of
CU. One of the first line treatments of CU with an-
hidrosis andor hypohidrosis is the pulse therapy
with a high dose of corticosteroid. The treatment may
decrease the lymphocytic infiltrate around the sweat
glands and allow acetylcholine receptor to re-express,
resulting in the improvement of sweating and CU.
Anti-histamines should be combined with other treat-
ments owing to the limited effect. Various therapeutic
variations including scopolamine,54 danazol,55,56 β2-
adrenergic stimulants57 and β2-adrenergic blockers58
have been reported, however, those therapies are the
second line treatments and recommended to be used
as combination therapies.
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